Corcept Therapeutics, Inc. (CORT)
55.08
-1.29
(-2.29%)
USD |
NASDAQ |
May 18, 16:00
55.50
+0.42
(+0.76%)
After-Hours: 19:41
Corcept Therapeutics Total Assets (Quarterly) : 814.88M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Merck & Co., Inc. | 128.68B |
| Supernus Pharmaceuticals, Inc. | 1.501B |
| Terns Pharmaceuticals, Inc. (DELISTED) | 1.025B |
| Assertio Holdings, Inc. | 211.30M |
| Nektar Therapeutics | 763.27M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 176.89M |
| Shareholders Equity (Quarterly) | 637.99M |
| Debt to Equity Ratio | 0.0151 |
| Current Ratio | 2.826 |
| Net Debt Paydown Yield | -0.01% |